Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-23

FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Teva Parenteral Medicines, Inc.)

View source ↗

Summary

FDA approved Teva Parenteral Medicines' palonosetron hydrochloride injection as an original application (ANDA 090713), establishing bioequivalence for preventio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

ORIG AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)